HER2 Testing in Metastatic Solid Tumors Beyond Breast and Gastric: Navigating an Evolving Landscape
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered

NEW On-Demand Webinar - released August 2026

The Florida Society of Pathologists (FSP), in partnership with AstraZeneca, invites you to watch an important and timely on-demand webinar. Antibody drug conjugate therapy is a rapidly expanding category of treatment considerations for cancer patients. Her2 IHC expression assists with identifying patients across a variety of tumor types. This presentation will present data about Her2 expression in a variety of tumors and clarify its use. 

There is no CME for this recorded webinar. 

Moderator: Marilyn M. Bui, MD, PhD
Faculty: Michelle Shiller, DO